The Role of Human Bone Morphogenetic Proteins in Spinal Fusion

&NA; The attainment of a stable arthrodesis is critical to the successful management of some types of spinal disorders. Autologous iliac‐crest bone graft has been the most commonly utilized substance associated with predictable healing in spinal fusion applications. Although alternative graft substances exist, these have not been shown to be as uniformly effective in achieving spinal fusion. Because of the morbidity associated with bone autograft harvest, there is increasing interest in alternative graft substances and especially in the osteoinductive abilities of bone morphogenetic proteins (BMPs). Several animal models have demonstrated that BMP‐containing allograft or synthetic carrier medium is as effective as or superior to autograft bone in promoting spinal fusion. Furthermore, the limited number of human trials utilizing BMPs to treat nonunions in the appendicular skeleton indicate that the results found in animal models will be reproducible in the clinical setting.

[1]  S. Boden,et al.  THE USE OF BMP-2 IN INTERBODY FUSION CAGES: DEFINITIVE EVIDENCE OF OSTEOINDUCTION IN HUMANS , 2002 .

[2]  L. Titus,et al.  1998 Volvo Award Winner in Basic Science Studies: Lumbar Spine Fusion by Local Gene Therapy With a cDNA Encoding a Novel Osteoinductive Protein (LMP‐1) , 1998, Spine.

[3]  M. Markel,et al.  Cervical Interbody Fusion Cages: An Animal Model With and Without Bone Morphogenetic Protein , 1998, Spine.

[4]  E. E. Johnson,et al.  One-stage lengthening of femoral nonunion augmented with human bone morphogenetic protein. , 1998, Clinical orthopaedics and related research.

[5]  J. Wozney,et al.  Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. , 1997, Journal of spinal disorders.

[6]  S. Boden,et al.  Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. , 1997, Journal of spinal disorders.

[7]  J. Wozney,et al.  Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. , 1997, Endocrinology.

[8]  J M Toth,et al.  Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein-2 Without Decortication of Osseous Elements , 1997, Spine.

[9]  S. Harris,et al.  Bone Morphogenetic Protein 2 (BMP-2) Enhances BMP-3, BMP-4, and Bone Cell Differentiation Marker Gene Expression During the Induction of Mineralized Bone Matrix Formation in Culturesof Fetal Rat Calvarial Osteoblasts , 1997, Calcified Tissue International.

[10]  S. Mohan,et al.  Osteogenic Protein-1 Stimulates mRNA Levels of BMP-6 and Decreases mRNA Levels of BMP-2 and -4 in Human Osteosarcoma Cells , 1997, Calcified Tissue International.

[11]  S. Boden,et al.  Video‐Assisted Lateral Intertransverse Process Arthrodesis: Validation of a New Minimally Invasive Lumbar Spinal Fusion Technique in the Rabbit and Nonhuman Primate (Rhesus) Models , 1996, Spine.

[12]  R. Delamarter,et al.  Effective Doses of Recombinant Human Bone Morphogenetic Protein‐2 in Experimental Spinal Fusion , 1996, Spine.

[13]  D. Kallmes,et al.  Molecular methods of enhancing lumbar spine fusion. , 1996, Neurosurgery.

[14]  J. Wozney,et al.  Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. , 1996, Endocrinology.

[15]  K. Lyons,et al.  Bone morphogenetic protein-2: biology and applications. , 1996, Clinical orthopaedics and related research.

[16]  J. Michael Kabo,et al.  Evaluation of rhBMP‐2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion Model , 1995, Spine.

[17]  Robert N. Hensinger,et al.  Annual Meeting of the American Academy of Orthopaedic Surgeons , 1995 .

[18]  W. Hutton,et al.  Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.

[19]  A. Reddi.  Bone and cartilage differentiation. , 1994, Current opinion in genetics & development.

[20]  V. Rosen,et al.  The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. , 1992, The Journal of bone and joint surgery. American volume.

[21]  E. Wang,et al.  Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. , 1991, Archives of otolaryngology--head & neck surgery.

[22]  M. Urist,et al.  Augmentation of spinal fusion with bone morphogenetic protein in dogs. , 1989, Clinical orthopaedics and related research.

[23]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[24]  M. Urist,et al.  Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. , 1988, Clinical orthopaedics and related research.

[25]  A. Burstein,et al.  The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. , 1984, The Journal of bone and joint surgery. American volume.

[26]  K. Takagi,et al.  The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. , 1982, Clinical orthopaedics and related research.

[27]  M. Urist,et al.  Solubilized and insolubilized bone morphogenetic protein. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[28]  V. Rosen,et al.  Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. , 1996, Growth factors.

[29]  R. Kaufman,et al.  Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells. , 1992, Growth factors.

[30]  F. C. Bauer,et al.  Human osteosarcoma-derived soluble bone morphogenetic protein. , 1981, Clinical orthopaedics and related research.

[31]  Urist Mr,et al.  Human osteosarcoma-derived soluble bone morphogenetic protein. , 1981 .